Latest News about SGMO

Recent news which mentions SGMO

< Previous 1 2 3 4 5 Next >

Sangamo's Fabry Disease Gene Therapy Continues To Show Encouraging Safety Profile

August 30, 2022

Sangamo Therapeutics's Return On Capital Employed Insights

August 22, 2022

Recap: Sangamo Therapeutics Q2 Earnings

August 04, 2022

12 Health Care Stocks Moving In Tuesday's After-Market Session

July 19, 2022

Stocks That Hit 52-Week Lows On Wednesday

May 25, 2022

The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study

May 05, 2022

Sangamo Therapeutics's Earnings: A Preview

May 04, 2022

Stocks That Hit 52-Week Lows On Tuesday

April 26, 2022

Stocks That Hit 52-Week Lows On Thursday

April 21, 2022

Stocks That Hit 52-Week Lows On Tuesday

April 19, 2022

Stocks That Hit 52-Week Lows On Tuesday

March 15, 2022

Sangamo Therapeutics: Q4 Earnings Insights

February 24, 2022

The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company

February 24, 2022

The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow

February 20, 2022

The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar

February 08, 2022

Sangamo Therapeutics Shares Updated Interim Data From Fabry Disease Gene Therapy Trial

February 08, 2022

Stocks That Hit 52-Week Lows On Friday

January 14, 2022

81 Biggest Movers From Yesterday

November 05, 2021

Sangamo Therapeutics, inc (SGMO) Q3 2021 Earnings Call Transcript

November 04, 2021

Why Did Sangamo Stock Jump 20% Today?

November 04, 2021

12 Health Care Stocks Moving In Thursday's Intraday Session

November 04, 2021

55 Stocks Moving In Thursday's Mid-Day Session

November 04, 2021

The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO

November 04, 2021

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline

October 31, 2021

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs

October 08, 2021

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results

October 07, 2021

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal

October 06, 2021

The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold

September 17, 2021

Stocks That Hit 52-Week Lows On Friday

August 20, 2021

The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data

August 20, 2021

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.